Daxor Corporation (DXR) - Financial and Strategic SWOT Analysis Review

Date: May 3, 2013
Pages: 40
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D1AF3A23671EN
Leaflet:

Download PDF Leaflet

Daxor Corporation (DXR) - Financial and Strategic SWOT Analysis Review
Summary

Daxor Corporation (Daxor) is an investment company with medical instrumentation and biotechnology operations. Its flagship product, BVA-100 Blood Volume Analyzer is an instrument to measure human blood volume. It is used in conjunction with Volumex , a single-use radiopharmaceutical diagnostic injection and collection kit. The company also offers cryobanking services including semen banking, autologous blood banking services, andrology services and general clinical laboratory testing through its subsidiary Scientific Medical Systems Corp.’s IDANT Laboratories division.

Daxor Corporation Key Recent Developments

Feb 14, 2013: Reports Of Study Comparing Daxor’s Direct Blood Volume Measurement With Non-invasive Hemoglobin Monitor In Critically Ill Surgical PatientsnNov 08, 2012: Daxor Announces Basic Blood Volume Research Study On Renal Dialysis Patients
Jun 29, 2012: Daxor Announces Filing Of Form N-2 And Seven Trial Agreements For Daxor BVA-100 Blood Volume Analyzer
Mar 28, 2012: Daxor Reports Revenue Of $1.4m In 2011

This comprehensive SWOT profile of Daxor Corporation provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY

Daxor Corporation - Key Facts
Daxor Corporation - Key Employees
Daxor Corporation - Key Employee Biographies
Daxor Corporation - Major Products and Services
Daxor Corporation - Medical Equipment Pipeline Products Data
Daxor Corporation Pipeline Products by Equipment Type
Daxor Corporation Pipeline Products by Development Stage
Daxor Corporation - History
Daxor Corporation - Company Statement
Daxor Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Daxor Corporation - Business Description
Daxor Corporation - SWOT Analysis
SWOT Analysis - Overview
Daxor Corporation - Strengths
Strength - BVA-100 Blood Volume Analyzer
Strength - Broad Service Offerings- Cryobanking Services
Strength - Improving Financial Position
Daxor Corporation - Weaknesses
Weakness - Dependence on Limited Manufacturer Base
Daxor Corporation - Opportunities
Opportunity - Growing Aged Population
Opportunity - Scientific Studies Employing BVA-100
Opportunity - Market Potential
Daxor Corporation - Threats
Threat - Rapid Technological Changes
Threat - Stringent Government Regulations
Threat - Cost Containment Pressures
Daxor Corporation - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Daxor Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013
Daxor Corporation, Medical Equipment, Deals By Type, 2007 to YTD 2013
Daxor Corporation, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Daxor Corporation, Recent Developments
Mar 07, 2013: Daxor Announces Sale Of BVA-100 Blood Volume Analyzer To Banner Good Samaritan Medical Center
Feb 14, 2013: Reports Of Study Comparing Daxor’s Direct Blood Volume Measurement With Non-invasive Hemoglobin Monitor In Critically Ill Surgical Patients
Jan 31, 2013: Christiana Medical Center Presents New Study Evaluating Hyponatremia Utilizing Daxor’s BVA-100 At Annual 2013 Critical Care Congress
Nov 19, 2012: Daxor Signs Trial Agreement With PCI Nuclear Pharmacy in Arizona For Blood Volume Analyzer-100
Nov 08, 2012: Daxor Announces Basic Blood Volume Research Study On Renal Dialysis Patients
Sep 24, 2012: Study At Columbia University Using Daxor's Blood Volume Analyzer Demonstrates Hidden Polycythemia In Heart Failure Patients
Aug 03, 2012: Daxor Announces Sale Of BVA-100 Blood Volume Analyzer To Hospital Located In Arizona
Jul 18, 2012: Daxor Announces Placement Of BVA-100 Blood Volume Analyzer At New York Presbyterian/Weill Cornell Medical Center
Jul 12, 2012: Daxor Announces Placement Of BVA-100 Blood Volume Analyzer At North Alabama Radiopharmacy
Jun 29, 2012: Daxor Announces Filing Of Form N-2 And Seven Trial Agreements For Daxor BVA-100 Blood Volume Analyzer

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Daxor Corporation, Key Facts
Daxor Corporation, Key Employees
Daxor Corporation, Key Employee Biographies
Daxor Corporation, Major Products and Services
Daxor Corporation Number of Pipeline Products by Equipment Type
Daxor Corporation Pipeline Products by Equipment Type
Daxor Corporation Number of Pipeline Products by Development Stage
Daxor Corporation Pipeline Products by Development Stage
Daxor Corporation, History
Daxor Corporation, Subsidiaries
Daxor Corporation, Key Competitors
Daxor Corporation, Ratios based on current share price
Daxor Corporation, Annual Ratios
Daxor Corporation, Interim Ratios
Daxor Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013
Daxor Corporation, Medical Equipment, Deals By Type, 2007 to YTD 2013
Daxor Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Daxor Corporation Pipeline Products by Equipment Type
Daxor Corporation Pipeline Products by Development Stage
Daxor Corporation, Performance Chart (2008 - 2012)
Daxor Corporation, Ratio Charts
Daxor Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013
Daxor Corporation, Medical Equipment, Deals by Type, 2007 to YTD 2013

Ask Your Question

Daxor Corporation (DXR) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: